360 Participants Needed

MyChildCMC App for Complex Medical Needs

Recruiting at 1 trial location
AZ
FL
Overseen ByFlory L Nkoy, MD, MS, MPH
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Utah
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Children with medical complexity (CMC) are the most vulnerable of children with chronic diseases, who have complex, multisystem chronic diseases affecting ≥3 organ systems, severe functional limitations and technology dependencies. CMC have high health care needs, and account for 40% of hospitalized children and 35% of all pediatric health care costs. Due to high medical fragility, CMC have frequent acute deteriorations superimposed on their chronic conditions, leading to recurrent emergency department (ED)/hospital admissions and affecting quality of life (QOL). To reduce ED/hospital admissions for CMC, remote monitoring is suggested, with use of mHealth apps to regularly assess their health status remotely and identify early signs of acute deterioration, allowing for early interventions to prevent ED/hospital admissions. Yet no app to support remote monitoring of CMC exists. Variable, multisystem conditions among CMC make it difficult to develop an app. Also, many CMC are at high-risk for health care inequities, with minorities having higher unmet needs, but the impacts of health care inequities and social determinants of health (SDOH) on ED/hospital admissions in CMC are rarely studied. Fortunately, ED/hospital admissions for CMC are often preceded by a limited set of shared (crosscutting) acute symptoms. These crosscutting symptoms rarely occur suddenly. Studies suggest that they usually start as subtle signs, often unnoticed by parents until they escalate to prompt an ED/hospital visit. Thus, crosscutting symptoms offer an opportunity for a novel and practical approach for developing a remote monitoring app for CMC, despite their multiple, variable underlying conditions. In a focus group, parents identified the crosscutting symptoms that most often preceded their children's hospital admissions, and conveyed their needs, preferences and key functionalities that led to MyChildCMC, the first app designed to monitor and identify early signs of crosscutting symptoms in CMC. In a pilot trial of 50 subjects, we confirmed feasibility of MyChildCMC use by parents, ability to detect early signs 2-14 days prior to ED/hospital admissions, and use leading significantly to fewer hospital days than controls. The current study will assess the efficacy and sustainability of MyChildCMC in a fully-powered 6-month, 2-arm (MyChildCMC vs usual care) trial of CMC (age 1-18 years) and their parents. Parents assigned to MyChildCMC will use the app daily for 6 months, both arms will receive financial incentive for participation, then we will stop the incentive and follow subjects for 6 more months to assess sustainability at 12 months. We will also assess if MyChildCMC use will help reduce or eliminate inequities in ED/hospital admissions. Specific Aims are: 1) Determine MyChildCMC's efficacy on 1.a. Child (ED/hospital use, hospital days and QOL) and 1.b. Parent (satisfaction, self-efficacy and stress) outcomes; 2) Compare ED/hospital use among racial/ethnic and SDOH subgroups to assess potential effect of MyChildCMC on inequities.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications. It seems likely that you can continue your current medications, but please confirm with the trial coordinators.

What data supports the effectiveness of the MyChildCMC app treatment for children with complex medical needs?

Research suggests that mobile health tools like the MyChildCMC app can help monitor symptoms at home, potentially reducing emergency visits and hospitalizations for children with complex medical needs. Caregivers believe such tools are beneficial for tracking early signs of health changes, which can lead to timely interventions.12345

Is the MyChildCMC app safe for use in children with complex medical needs?

The MyChildCMC app has been designed to help monitor children with complex medical needs at home, aiming to reduce emergency visits and hospitalizations. While specific safety data for the app itself isn't detailed, similar apps have been used to improve medication safety and have been found easy to use by parents, suggesting a focus on safety in its design.12367

How is the MyChildCMC app treatment different from other treatments for children with medical complexity?

The MyChildCMC app is unique because it focuses on home monitoring to detect early health deteriorations and reduce emergency visits and hospitalizations for children with complex medical needs. Unlike traditional treatments, it uses mobile technology to support caregivers in managing the child's health at home, potentially improving medication safety and care coordination.138910

Research Team

FN

Flory Nkoy, MD, MS, MPH

Principal Investigator

University of Utah

Eligibility Criteria

This trial is for children aged 1-18 with complex medical needs affecting multiple organ systems, severe functional limitations, and technology dependencies. It aims to help those who have frequent hospital visits and are at risk of health care inequities.

Inclusion Criteria

CMC (inpatients or outpatients) who receive care at participating sites (comprehensive care clinics for CMC)
Own (or provided) a smartphone or tablet with internet access
I have a chronic condition affecting 3 or more organ systems, see multiple doctors, and have been frequently hospitalized or depend on medical technology.

Exclusion Criteria

No one will be excluded due to lack of smartphone/internet access. We estimated <10% of families may not have a smartphone/internet, and will provide them low-cost tablets and cellular internet access.
My child is critically ill.
My child is older than 1 year and does not have conditions related to being born early.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use the MyChildCMC app daily for 6 months to monitor crosscutting symptoms and receive feedback

6 months
Daily app usage

Follow-up

Participants are monitored for sustainability of app usage and outcomes without financial incentives

6 months

Treatment Details

Interventions

  • MyChildCMC app
Trial Overview The MyChildCMC app is being tested in a study where one group uses the app daily for remote monitoring of their child's health, while another receives usual care. The goal is to see if the app can reduce emergency/hospital visits and improve quality of life.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: MyChildCMC groupExperimental Treatment1 Intervention
MyChildCMC is an app designed to support remote monitoring of CMC crosscutting symptoms to identify signs of CMC's health deterioration early to change their care early to avoid progression and prevent ED/hospital admissions. The app includes the following features: 1) automated reminders, 2) vital sign/symptom monitoring, 3) real-time feedback system, 4) automated and real-time summary reports with longitudinal graphs, 5) automated alerts to a care coordinator, and 6) clinic dashboard connecting patients to clinics and allowing access to patient data to support care coordination. Those randomized to MyChildCMC will use the app daily for 6 months to monitor vital signs/symptoms. They will also receive a sensor (Masimo Mighty Sat) to facilitate collection of Oxygen saturation, heart rate and respiratory rate, as well as financial incentive for daily monitoring (monitoring incentive) for 6-months and for responding to surveys.
Group II: Usual care groupActive Control1 Intervention
Those assigned to usual care will use a paper diary to monitor their vital signs and symptoms daily for 6 months. They will also receive a sensor (Masimo Mighty Sat) to facilitate collection of Oxygen saturation, heart rate and respiratory rate, as well as financial incentive for daily monitoring (monitoring incentive) for 6-months and for responding to surveys.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Utah

Lead Sponsor

Trials
1,169
Recruited
1,623,000+

National Institute of Nursing Research (NINR)

Collaborator

Trials
623
Recruited
10,400,000+

Findings from Research

The study involved 16 participants, including family caregivers and clinicians, who identified 11 medication safety challenges faced by caregivers of children with medical complexity, highlighting the need for better support in medication management.
Design requirements for a mobile health application were developed to enhance medication safety by improving communication and ensuring timely administration, with plans for future testing to evaluate its effectiveness in reducing medication errors.
An mHealth design to promote medication safety in children with medical complexity.Jolliff, A., Coller, RJ., Kearney, H., et al.[2023]
In a 1-year study involving 310 parents of children with chronic diseases, the incidence of medication errors (MEs) was found to be 0.46 errors per child, with the highest risk observed in children under 1 year old (1.69 errors per child).
Children discharged from the cardiology unit had a significantly higher risk of medication errors (IRR of 3.66), highlighting the need for targeted monitoring and support for this vulnerable group.
A Cell-Phone Medication Error eHealth App for Managing Safety in Chronically Ill Young Patients at Home: A Prospective Study.Tiozzo, E., Rosati, P., Brancaccio, M., et al.[2023]
A point-of-care screening algorithm was successfully implemented to identify children with medical complexity (CMC) among hospitalized patients, categorizing 2187 inpatients into three groups based on their health care needs.
Children identified as CMC had significantly more complex chronic conditions and higher hospital resource use compared to those with special health care needs or previously healthy children, indicating they are a key group that could benefit from enhanced care coordination services.
Point-of-Care Complexity Screening Algorithm to Identify Children With Medical Complexity.Parente, V., Parnell, L., Childers, J., et al.[2022]

References

Home-Monitoring Application for Children With Medical Complexity: A Feasibility Trial. [2021]
Information needs for designing a home monitoring system for children with medical complexity. [2019]
An mHealth design to promote medication safety in children with medical complexity. [2023]
Codesign and Usability Testing of a Mobile Application to Support Family-Delivered Enteral Tube Care. [2021]
Mobile Complex Care Plans to Enhance Parental Engagement for Children With Medical Complexity. [2019]
A Cell-Phone Medication Error eHealth App for Managing Safety in Chronically Ill Young Patients at Home: A Prospective Study. [2023]
Hospital admission medication reconciliation in medically complex children: an observational study. [2010]
Children With Medical Complexity: The 10-Year Experience of a Single Center. [2021]
Point-of-Care Complexity Screening Algorithm to Identify Children With Medical Complexity. [2022]
Feasibility of implementing systematic social needs assessment for children with medical complexity. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security